(SCM) Stellus Capital Investment - Overview
Sector: Financial Services | Industry: Asset Management | Exchange: NYSE (USA) | Market Cap: 271m USD | Total Return: -11.1% in 12m
Industry Rotation: +4.4
Avg Turnover: 1.57M USD
Peers RS (IBD): 11.6
EPS Trend: -21.7%
Qual. Beats: 0
Rev. Trend: 67.5%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Stellus Capital Investment (SCM) is a business development company (BDC) that provides debt and equity financing to private middle-market companies.
BDCs are a type of closed-end investment company that invest in small and mid-sized companies, often privately held. SCMs investment strategy includes first lien, second lien, unitranche, and mezzanine debt, frequently paired with an equity component. This allows for diverse financing solutions for portfolio companies.
The company targets investments in the US and Canada, focusing on businesses with EBITDA between $5 million and $50 million. This segment of the market often has limited access to traditional bank financing, creating opportunities for BDCs.
For a deeper dive into SCMs performance metrics and financial health, consider exploring its profile on ValueRay.
- Middle-market loan demand impacts investment volume
- Interest rate fluctuations affect net investment income
- Credit quality of portfolio companies drives returns
- Regulatory changes for BDCs create operational risks
| Net Income: 27.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 80.32 > 0.02 and ΔFCF/TA 8.04k > 1.0 |
| NWC/Revenue: -112k% < 20% (prev 20.41%; Δ -112k% < -1%) |
| CFO/TA -0.00 > 3% & CFO -26.4m > Net Income 27.0m |
| Current Ratio: 0.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.4m) vs 12m ago 10.82% < -2% |
| Gross Margin: 69.73% > 18% (prev 0.55%; Δ 6.92k% > 0.5%) |
| Asset Turnover: 0.02% > 50% (prev 8.57%; Δ -8.55% > 0%) |
| Interest Coverage Ratio: 0.52 > 6 (EBITDA TTM 63.6m / Interest Expense TTM 34.9m) |
| A: -0.09 (Total Current Assets 31.51b - Total Current Liabilities 123.25b) / Total Assets 1041.25b |
| B: -0.00 (Retained Earnings -26.7m / Total Assets 1041.25b) |
| C: 0.00 (EBIT TTM 18.1m / Avg Total Assets 521.12b) |
| D: 0.00 (Book Value of Equity 2.27m / Total Liabilities 670.07b) |
| Altman-Z'' Score: -0.58 = B |
Over the past week, the price has changed by +5.25%, over one month by +14.16%, over three months by -23.42% and over the past year by -11.08%.
- StrongBuy: 1
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 11 | 12% |
P/E Forward = 8.8183
P/S = 2.6499
P/B = 0.7292
Revenue TTM = 81.9m USD
EBIT TTM = 18.1m USD
EBITDA TTM = 63.6m USD
Long Term Debt = 651.8m USD (from longTermDebt, last quarter)
Short Term Debt = 122.67b USD (from shortTermDebt, last quarter)
Debt = 418.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 393.61b USD (from netDebt column, last quarter)
Enterprise Value = 418.90b USD (270.7m + Debt 418.66b - CCE 25.1m)
Interest Coverage Ratio = 0.52 (Ebit TTM 18.1m / Interest Expense TTM 34.9m)
EV/FCF = 0.01x (Enterprise Value 418.90b / FCF TTM 83638.26b)
FCF Yield = 20.0k% (FCF TTM 83638.26b / Enterprise Value 418.90b)
FCF Margin = 102.1m% (FCF TTM 83638.26b / Revenue TTM 81.9m)
Net Margin = 33.00% (Net Income TTM 27.0m / Revenue TTM 81.9m)
Gross Margin = 69.73% ((Revenue TTM 81.9m - Cost of Revenue TTM 24.8m) / Revenue TTM)
Gross Margin QoQ = none% (prev 48.66%)
Tobins Q-Ratio = 0.40 (Enterprise Value 418.90b / Total Assets 1041.25b)
Interest Expense / Debt = 0.00% (Interest Expense 9.05m / Debt 418.66b)
Taxrate = 2.54% (136k / 5.35m)
NOPAT = 17.6m (EBIT 18.1m * (1 - 2.54%))
Current Ratio = 0.26 (Total Current Assets 31.51b / Total Current Liabilities 123.25b)
Debt / Equity = 1.13 (Debt 418.66b / totalStockholderEquity, last quarter 371.18b)
Debt / EBITDA = 6.19k (out of range, set to none) (Net Debt 393.61b / EBITDA 63.6m)
Debt / FCF = 0.00 (Net Debt 393.61b / FCF TTM 83638.26b)
Total Stockholder Equity = 93.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.01% (Net Income 27.0m / Total Assets 1041.25b)
RoE = 0.03% (Net Income TTM 27.0m / Total Stockholder Equity 93.08b)
RoCE = 0.02% (EBIT 18.1m / Capital Employed (Equity 93.08b + L.T.Debt 651.8m))
RoIC = 1.74% (NOPAT 17.6m / Invested Capital 1.01b)
WACC = 0.01% (E(270.7m)/V(418.93b) * Re(8.01%) + D(418.66b)/V(418.93b) * Rd(0.00%) * (1-Tc(0.03)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.43%
[DCF] Terminal Value 80.82% ; FCFF base≈83638.26b ; Y1≈54912.42b ; Y5≈25111.70b
[DCF] Fair Price = 27.5m (EV 797112.83b - Net Debt 393.61b = Equity 796719.23b / Shares 28.9m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
[DCF] Fair Price = 27.5m (out of range, set to none)
EPS Correlation: -21.73 | EPS CAGR: 0.94% | SUE: -0.50 | # QB: 0
Revenue Correlation: 67.46 | Revenue CAGR: 29.13% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.26 | Chg7d=-0.028 | Chg30d=-0.028 | Revisions Net=-2 | Analysts=5
EPS current Year (2026-12-31): EPS=1.03 | Chg7d=-0.106 | Chg30d=-0.106 | Revisions Net=-4 | Growth EPS=-20.6% | Growth Revenue=-7.2%
EPS next Year (2027-12-31): EPS=1.05 | Chg7d=-0.055 | Chg30d=-0.055 | Revisions Net=-1 | Growth EPS=+1.7% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -2.2% (Discount Rate 8.0% - Earnings Yield 10.2%)
[Growth] Growth Spread = -1.2% (Analyst -3.4% - Implied -2.2%)